-
1
-
-
0034900986
-
Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations
-
B.J Maron H Niimura S.A Casey Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations J Am Coll Cardiol 38 2001 315 321
-
(2001)
J Am Coll Cardiol
, vol.38
, pp. 315-321
-
-
Maron, B.J1
Niimura, H2
Casey, S.A3
-
2
-
-
0032499634
-
Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene
-
P Charron O Dubourg M Desnos Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene Circulation 97 1998 2230 2236
-
(1998)
Circulation
, vol.97
, pp. 2230-2236
-
-
Charron, P1
Dubourg, O2
Desnos, M3
-
3
-
-
0034724252
-
A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance
-
J.A Moolman S Reith K Uhl A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance Circulation 101 2000 1396 1402
-
(2000)
Circulation
, vol.101
, pp. 1396-1402
-
-
Moolman, J.A1
Reith, S2
Uhl, K3
-
4
-
-
0032580520
-
Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy
-
H Niimura L.L Bachinski S Sangwatanaroj Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy N Engl J Med 338 1998 1248 1257
-
(1998)
N Engl J Med
, vol.338
, pp. 1248-1257
-
-
Niimura, H1
Bachinski, L.L2
Sangwatanaroj, S3
-
5
-
-
0026099642
-
An atypical variant of Fabry’s disease with manifestations confined to the myocardium
-
W von Scheidt C.M Eng T.F Fitzmaurice An atypical variant of Fabry’s disease with manifestations confined to the myocardium N Engl J Med 324 1991 395 399
-
(1991)
N Engl J Med
, vol.324
, pp. 395-399
-
-
von Scheidt, W1
Eng, C.M2
Fitzmaurice, T.F3
-
6
-
-
0025971051
-
Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of alpha-galactosidase A
-
Y Nagao H Nakashima Y Fukuhara Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of alpha-galactosidase A Clin Genet 39 1991 233 237
-
(1991)
Clin Genet
, vol.39
, pp. 233-237
-
-
Nagao, Y1
Nakashima, H2
Fukuhara, Y3
-
7
-
-
0343618421
-
New insights in cardiac structural changes in patients with Fabry’s disease
-
A Linhart T Palecek J Bultas New insights in cardiac structural changes in patients with Fabry’s disease Am Heart J 139 2000 1101 1108
-
(2000)
Am Heart J
, vol.139
, pp. 1101-1108
-
-
Linhart, A1
Palecek, T2
Bultas, J3
-
8
-
-
0001454252
-
Concealed myocardial storage disease (Fabry’s disease): pitfalls in the diagnosis of hypertrophic nonobstructive cardiomyopathy (abstr)
-
H Kuhn E Kohler W Hort H Frenzel Concealed myocardial storage disease (Fabry’s disease) pitfalls in the diagnosis of hypertrophic nonobstructive cardiomyopathy (abstr) Circulation Suppl II 1982 117
-
(1982)
Circulation
, vol.Suppl II
, pp. 117
-
-
Kuhn, H1
Kohler, E2
Hort, W3
Frenzel, H4
-
9
-
-
0029023150
-
An atypical variant of Fabry’s disease in men with left ventricular hypertrophy
-
S Nakao T Takenaka M Maeda An atypical variant of Fabry’s disease in men with left ventricular hypertrophy N Engl J Med 333 1995 288 293
-
(1995)
N Engl J Med
, vol.333
, pp. 288-293
-
-
Nakao, S1
Takenaka, T2
Maeda, M3
-
10
-
-
0035811674
-
Improvement in cardiac function in the cardiac variant of Fabry’s disease with galactose-infusion therapy
-
A Frustaci C Chimenti R Ricci Improvement in cardiac function in the cardiac variant of Fabry’s disease with galactose-infusion therapy N Engl J Med 345 2001 25 32
-
(2001)
N Engl J Med
, vol.345
, pp. 25-32
-
-
Frustaci, A1
Chimenti, C2
Ricci, R3
-
11
-
-
0035811624
-
Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry’s disease
-
C.M Eng N Guffon W.R Wilcox Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry’s disease N Engl J Med 345 2001 9 16
-
(2001)
N Engl J Med
, vol.345
, pp. 9-16
-
-
Eng, C.M1
Guffon, N2
Wilcox, W.R3
|